Edition:
United States

Eli Lilly and Co (LLY.F)

LLY.F on Frankfurt Stock Exchange

73.31EUR
20 Oct 2017
Change (% chg)

€0.86 (+1.18%)
Prev Close
€72.45
Open
€72.89
Day's High
€73.62
Day's Low
€72.89
Volume
355
Avg. Vol
1,052
52-wk High
€81.75
52-wk Low
€59.00

Select another date:

Thu, Oct 19 2017

BRIEF-Novo Nordisk VP says seeks market share from Eli Lilly with semaglutide

Oct 19 NOVO NORDISK CHIEF SCIENTIFIC OFFICER MADS KROGSGAARD THOMSEN SAYS IN INTERVIEW:

BRIEF-Eli Lilly ‍declares Q4 dividend of $0.52/share

* Declared a dividend for Q4 of 2017 of $0.52 per share on outstanding common stock​ Source text for Eikon: Further company coverage:

BRIEF-Eli Lilly sets quarterly dividend of $0.52 per share

* Sets quarterly dividend of $0.52 per share Source text for Eikon: Further company coverage:

BRIEF-‍BIOLOGICS SAYS SELECTED BY ELI LILLY TO BE IN LIMITED DISTRIBUTION NETWORK FOR VERZENIO​

* ‍BIOLOGICS INC SAYS HAS BEEN SELECTED BY ELI LILLY AND COMPANY TO BE IN LIMITED DISTRIBUTION NETWORK FOR VERZENIO​ Source text for Eikon: Further company coverage:

BRIEF-U.S. PTO rules in Eli Lilly's favor on Alimta

* Patent trial and appeal board of U.S. PTO ruled in company's favor regarding patentability of vitamin regimen for Alimta

BRIEF-Eli lilly says Lilly Endowment Inc reports open market sale of 205,000 shares of co's common stock on Oct. 4

* Eli lilly and co says Lilly Endowment Inc reports open market sale of 205,000 shares of co's common stock on OCT. 4 at average price of $86.805 per share - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Eli Lilly's ‍Humalog Junior Kwikpen now available by prescription in U.S.​

* Eli Lilly and Co - ‍Humalog Junior Kwikpen now available by prescription for treatment of diabetes in U.S.​ Source text for Eikon: Further company coverage:

BRIEF-Eli lilly says lilly endowment reports open market sale of co's common stock

* Eli Lilly And Co says Lilly Endowment Inc reports open market sale of 162,557 shares of co's common stock at average of $85.1/shr‍​ on Sept 29 - sec filing

BRIEF-Eli Lilly appoints ‍Josh Smiley as chief financial officer​

* Eli Lilly and Co - ‍josh Smiley has been promoted to senior vice president and chief financial officer​

BRIEF-Eli Lilly sets list price of new breast cancer drug at $10,948/month

* Eli Lilly says list price of new breast cancer drug Verzenio to be about $10,948 per month

Select another date: